Sucampo Pharmaceuticals Inc (SCMP)

11.46
0.09 0.79
NASDAQ : Health Care
Prev Close 11.37
Open 11.31
Day Low/High 11.28 / 11.49
52 Wk Low/High 9.59 / 29.67
Volume 48.76K
Avg Volume 468.60K
Exchange NASDAQ
Shares Outstanding 45.79M
Market Cap 522.45M
EPS 0.80
P/E Ratio 21.94
Div & Yield N.A. (N.A)

Latest News

Weak On High Volume: Sucampo Pharmaceuticals (SCMP)

Weak On High Volume: Sucampo Pharmaceuticals (SCMP)

Trade-Ideas LLC identified Sucampo Pharmaceuticals (SCMP) as a weak on high relative volume candidate

Jim Cramer's 'Mad Money' Recap: These Stocks Went From Trash to Treasure

Jim Cramer's 'Mad Money' Recap: These Stocks Went From Trash to Treasure

It's an irrational time for the stock market, Cramer says.

Sucampo Standardizes On Veeva Vault For A Single Source Of Truth Enterprise-wide

Sucampo Standardizes On Veeva Vault For A Single Source Of Truth Enterprise-wide

Veeva Systems (NYSE:VEEV) announced today that Sucampo Pharmaceuticals (NASDAQ:SCMP), a fast-growing global biopharmaceutical company, has standardized on the Veeva Vault platform and suite of applications to provide a...

Bearish Bets: 5 Stocks That Look Good Short

FC, BPT, BGFV, SCMP and LNN were all recently downgraded by TheStreet’s Quant Ratings.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CHMT, FMC, GHC, IBM, MGA, MUX, NVTA, PDVW, RAS Downgrades: SCMP, UEPS Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

RSI Alert: Sucampo Pharmaceuticals (SCMP) Now Oversold

RSI Alert: Sucampo Pharmaceuticals (SCMP) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Sucampo (SCMP) Stock Plunges Despite Strong Q4 Results

Sucampo (SCMP) Stock Plunges Despite Strong Q4 Results

Sucampo (SCMP) stock is slipping in mid-afternoon trading on Wednesday despite the company reporting strong 2015 fourth quarter results.

Trade-Ideas: Sucampo Pharmaceuticals (SCMP) Is Today's Weak On High Relative Volume Stock

Trade-Ideas: Sucampo Pharmaceuticals (SCMP) Is Today's Weak On High Relative Volume Stock

Trade-Ideas LLC identified Sucampo Pharmaceuticals (SCMP) as a weak on high relative volume candidate

Sucampo Pharmaceuticals (SCMP) Flagged As Strong On High Volume

Sucampo Pharmaceuticals (SCMP) Flagged As Strong On High Volume

Trade-Ideas LLC identified Sucampo Pharmaceuticals (SCMP) as a strong on high relative volume candidate

Interesting SCMP Put And Call Options For September 16th

Interesting SCMP Put And Call Options For September 16th

Investors in Sucampo Pharmaceuticals Inc saw new options become available this week, for the September 16th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 220 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Sucampo Pharmaceuticals Becomes Oversold (SCMP)

Sucampo Pharmaceuticals Becomes Oversold (SCMP)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Commit To Purchase Sucampo Pharmaceuticals At $10, Earn 19% Annualized Using Options

Commit To Purchase Sucampo Pharmaceuticals At $10, Earn 19% Annualized Using Options

Investors eyeing a purchase of Sucampo Pharmaceuticals Inc stock, but tentative about paying the going market price of $14.01/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the June put at the $10 strike, which has a bid at the time of this writing of 75 cents.

5 Stocks Ready for Breakouts

5 Stocks Ready for Breakouts

These stocks look ready to break out and trade higher from current levels.